$1.11
0.065.71%
At close: -
$1.08
-0.03-2.70%
After Hours: 4:46 PM EDT
Comments
Loading...
Opus Genetics (NASDAQ:IRD) Stock, Earnings Estimates, EPS, And Revenue
Opus Genetics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 12
EPS
$-0.290
Quarterly Revenue
$3.9M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$8.4M
Analyze the earnings history of Opus Genetics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Opus Genetics (IRD) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Opus Genetics (IRD) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Opus Genetics (NASDAQ:IRD) reporting earnings?
Opus Genetics (IRD) is scheduled to report earnings on February 15, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
What were the latest earnings per share (EPS) for Opus Genetics (NASDAQ:IRD)?
The Actual EPS was $-0.29, which missed the estimate of $0.00.
What were Opus Genetics’s (NASDAQ:IRD) revenues?
The Actual Revenue was $3.9M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.